tiprankstipranks
Trending News
More News >
Kansas City Life Insurance Company (KCLI)
OTHER OTC:KCLI
US Market

Kansas City Life Insurance Company (KCLI) AI Stock Analysis

Compare
15 Followers

Top Page

KCLI

Kansas City Life Insurance Company

(OTC:KCLI)

Select Model
Select Model
Select Model
Neutral 49 (OpenAI - 5.2)
Rating:49Neutral
Price Target:
$32.00
▼(-3.76% Downside)
The score is held back primarily by weak cash generation and volatile profitability (including a return to losses in 2024), partially offset by a conservatively positioned balance sheet with no reported debt. Technical indicators are broadly neutral, and valuation is difficult to assess given negative earnings despite a modest dividend yield.
Positive Factors
Debt-Free Balance Sheet
Having no debt enhances financial stability and flexibility, allowing KCLI to navigate economic fluctuations without the burden of interest payments, which is a strong long-term advantage.
Solid Equity Structure
A strong equity base provides a cushion against financial downturns and supports future growth initiatives, indicating robust financial health and resilience.
Gross Profit Margin
Maintaining a high gross profit margin reflects efficient cost management and pricing strategy, which is crucial for sustaining profitability in the competitive insurance sector.
Negative Factors
Negative Revenue Growth
Declining revenue growth indicates challenges in market expansion and customer acquisition, potentially impacting long-term profitability and market position.
Operating Cash Flow Challenges
Persistent negative operating cash flow suggests inefficiencies in core operations, which could strain liquidity and limit the company's ability to invest in growth opportunities.
Net Loss and Profitability Issues
Inconsistent profitability and recent net losses highlight operational challenges, undermining investor confidence and the company's ability to generate shareholder value.

Kansas City Life Insurance Company (KCLI) vs. SPDR S&P 500 ETF (SPY)

Kansas City Life Insurance Company Business Overview & Revenue Model

Company DescriptionKansas City Life Insurance Company provides insurance products and services in 49 states and the District of Columbia. It offers a portfolio of individual insurance, annuity, and group life and health insurance; and traditional life insurance, immediate annuities with life contingencies, supplementary contracts with life contingencies, and accident and health insurance. Kansas City Life Insurance Company was incorporated in 1985 and is based in Kansas City, Missouri.
How the Company Makes MoneyKansas City Life Insurance Company generates revenue primarily through the sale of life insurance policies and annuity products. The company earns premiums from policyholders, which serve as the primary source of income. Additionally, KCLI invests the premiums collected in various financial instruments, such as bonds, equities, and real estate, to generate investment income. This investment income complements the premium revenue and helps the company meet its future policyholder obligations. The company may also earn fees from managing group insurance plans and other financial products. Significant partnerships with financial advisors and insurance brokers can enhance distribution channels, contributing to the company's revenue growth.

Kansas City Life Insurance Company Financial Statement Overview

Summary
Financials are mixed: the balance sheet is a clear strength with no reported debt and meaningful equity, but performance quality is weakened by volatile profitability (2024 returning to a net loss with margin compression) and persistently negative operating/free cash flow, indicating limited self-funding capacity.
Income Statement
41
Neutral
Revenue has been broadly flat to down over time (2024 declined vs. 2023; 2022 also contracted), and profitability has been volatile. After a strong 2023 (positive net margin ~9.8%), results deteriorated in 2024 with a small net loss and negative EBIT/EBITDA margins, indicating weaker underwriting/investment results or higher costs. Gross profit margin also compressed meaningfully from 2023 to 2024, highlighting pressure on core economics.
Balance Sheet
72
Positive
The balance sheet shows no reported debt across the period, which materially reduces financial risk and provides flexibility. Equity is substantial relative to the business size, though it has trended down from 2020–2021 highs, and returns on equity have swung from solid in 2023 (~9.0%) to slightly negative in 2024, reflecting earnings instability. Overall leverage looks conservative, but profitability-driven capital rebuilding is a key watch item.
Cash Flow
28
Negative
Cash generation is a consistent weakness: operating cash flow and free cash flow are negative in most years shown (including 2021–2024), with 2024 notably negative. While free cash flow to net income appears mechanically around ~1x in several years, the more important takeaway is persistent cash burn and limited self-funding capacity, which increases reliance on portfolio actions or balance-sheet resources during weaker earnings periods.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue482.13M490.74M494.97M475.95M494.65M509.28M
Gross Profit125.23M126.33M120.51M103.98M100.83M107.38M
EBITDA-48.55M-2.80M74.56M-14.16M20.89M24.45M
Net Income-37.45M-4.96M54.92M-16.22M10.70M15.17M
Balance Sheet
Total Assets4.99B5.02B4.64B4.97B5.43B5.46B
Cash, Cash Equivalents and Short-Term Investments249.70M274.35M9.70M2.27B3.17B3.25B
Total Debt0.000.000.000.000.000.00
Total Liabilities4.41B4.44B4.44B4.08B4.20B4.55B
Stockholders Equity582.60M581.45M609.36M491.69M830.43M908.74M
Cash Flow
Free Cash Flow-108.25M-59.67M-51.45M-54.87M-46.95M4.08M
Operating Cash Flow-107.17M-58.37M-50.54M-54.33M-46.32M5.89M
Investing Cash Flow13.12M-13.01M-2.60M-89.17M-7.86M-34.02M
Financing Cash Flow94.62M69.78M55.07M145.85M52.40M21.10M

Kansas City Life Insurance Company Technical Analysis

Technical Analysis Sentiment
Positive
Last Price33.25
Price Trends
50DMA
32.49
Positive
100DMA
31.99
Positive
200DMA
31.44
Positive
Market Momentum
MACD
0.10
Positive
RSI
54.33
Neutral
STOCH
79.58
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For KCLI, the sentiment is Positive. The current price of 33.25 is above the 20-day moving average (MA) of 33.07, above the 50-day MA of 32.49, and above the 200-day MA of 31.44, indicating a bullish trend. The MACD of 0.10 indicates Positive momentum. The RSI at 54.33 is Neutral, neither overbought nor oversold. The STOCH value of 79.58 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for KCLI.

Kansas City Life Insurance Company Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
$3.64B4.3416.27%27.71%
68
Neutral
$51.60M11.224.75%0.74%11.99%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
63
Neutral
$3.55B16.812.86%1.41%150.35%
59
Neutral
$296.75M27.625.02%-0.55%-51.14%
49
Neutral
$320.89M-9.01-5.65%1.75%-3.32%-162.81%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
KCLI
Kansas City Life Insurance Company
33.14
-0.73
-2.16%
AAME
Atlantic American
2.53
0.97
62.18%
CIA
Citizens
5.90
0.35
6.31%
GNW
Genworth Financial
8.88
1.68
23.33%
BHF
Brighthouse Financial
63.70
5.21
8.91%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 30, 2025